A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: trastuzumab|DRUG: paclitaxel|DRUG: Myocet
Sponsor: Hoffmann-La Roche